-
OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Author: Zheng H, Wang C, He JW, Fu WZ, Zhang ZL.
Journal: Pharmacogenet Genomics. 2016 Jan;26(1):12-9. doi: 10.1097/FPC.0000000000000181.
-
Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
Author: Lv J, Hu L, Zhuo W, Zhang C, Zhou H, Fan L.
Journal: Pharmacogenet Genomics. 2016 Feb;26(2):80-7. doi: 10.1097/FPC.0000000000000190.
-
A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure.
Author: Jackson JN, Long KM, He Y, Motsinger-Reif AA, McLeod HL, Jack J.
Journal: Pharmacogenet Genomics. 2016 Jan 1. [Epub ahead of print]
-
Association of KCNQ1 polymorphisms with gliclazide efficacy in Chinese type 2 diabetic patients.
Author: Duan F, Guo Y, Zhang L, Chen P, Wang X, Liu Z, Hu Y, Chen S, Chen D.
Journal: Pharmacogenet Genomics. 2016 Feb 10. [Epub ahead of print]
-
Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses?
Author: Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Xu X, Huo Y.
Journal: Pharmacogenet Genomics. 2012 Jun;22(6):421-8. doi: 10.1097/FPC.0b013e32834ac5e8.
-
Integrating interacting drugs and genetic variations to improve the predictability of warfarin maintenance dose in Chinese patients.
Author: Zhong SL, Yu XY, Liu Y, Xu D, Mai LP, Tan HH, Lin QX, Yang M, Lin SG.
Journal: Pharmacogenet Genomics. 2012 Mar;22(3):176-82. doi: 10.1097/FPC.0b013e32834f45f9.
-
Effects of CYP2C19 variant alleles on postclopidogrel platelet reactivity and clinical outcomes in an actual clinical setting in China.
Author: Wu H, Qian J, Xu J, Sun A, Sun W, Wang Q, Ge J.
Journal: Pharmacogenet Genomics. 2012 Dec;22(12):887-90. doi: 10.1097/FPC.0b013e328359253a.
-
Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy.
Author: Hu L, Zhuo W, He YJ, Zhou HH, Fan L.
Journal: Pharmacogenet Genomics. 2012 Nov;22(11):812-9. doi: 10.1097/FPC.0b013e328358d92b.
